License Agreements
All Business Industries
Cerecor Inc. (123) | License Agreements (9)
- License Agreement, dated July 29, 2022, by and between Apollo AP43 Limited and Avalo Therapeutics, Inc (Filed With SEC on November 7, 2022)
- Exclusive Patent License Agreement, dated June 22, 2021, by and between Sanford Burnham Prebys Medical Discovery Institute and Cerecor Inc (Filed With SEC on August 2, 2021)
- License Agreement, dated March 25, 2021, by and between Cerecor Inc. and Kyowa Hakko Kirin Co., Ltd (Filed With SEC on May 13, 2021)
- Amendment No. 6 to License Agreement, dated as of November 16, 2020, by and between Medgenics Medical Israel Ltd. and The Children's Hospital of Philadelphia (Filed With SEC on November 20, 2020)
- Assignment of License Agreement, dated August 8, 2019, entered into by and between Cerecor Inc., ES Therapeutics, LLC, and Armistice Capital Master Fund Ltd (Filed With SEC on March 11, 2020)
- License and Development Agreement, dated February 16, 2018, by and between Cerecor Inc. and Flamel Ireland Limited (Filed With SEC on May 11, 2018)
- CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT by and between Eli Lilly and Company and CERECOR INC. Effective Date of September 08, 2016 (Filed With SEC on November 8, 2016)
- EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT by and between ESSEX CHEMIE AG and CERECOR INC. (Filed With SEC on June 12, 2015)
- EXCLUSIVE PATENT AND KNOW-HOW LICENSE AGREEMENT by and between ESSEX CHEMIE AG and CERECOR INC. (Filed With SEC on June 12, 2015)